Status: current, Defined. Date: 31-May 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4713321000168116 | Prolanza (olanzapine 5 mg) tablet, 30 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4713331000168118 | Prolanza 5 mg tablet, 30 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Prolanza 5 mg tablet, 30 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Prolanza 5 mg tablet, 30 | Is a | olanzapine 5 mg tablet, 30 | true | Inferred relationship | Some | ||
| Prolanza 5 mg tablet, 30 | has TP | Prolanza | true | Inferred relationship | Some | ||
| Prolanza 5 mg tablet, 30 | has TPUU | Prolanza 5 mg tablet | true | Inferred relationship | Some | 1088426634 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Prolanza 5 mg tablet, 30, blister pack | Is a | True | Prolanza 5 mg tablet, 30 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR